Layer-by-layer biofunctionalization of nanostructured porous silicon for high-sensitivity and high-selectivity label-free affinity biosensing by Mariani, Stefano et al.
ARTICLE
Layer-by-layer biofunctionalization of
nanostructured porous silicon for high-sensitivity
and high-selectivity label-free afﬁnity biosensing
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Nanostructured materials premise to revolutionize the label-free biosensing of analytes for
clinical applications, leveraging the deeper interaction between materials and analytes with
comparable size. However, when the characteristic dimension of the materials reduces to the
nanoscale, the surface functionalization for the binding of bioreceptors becomes a complex
issue that can affect the performance of label-free biosensors. Here we report on an effective
and robust route for surface biofunctionalization of nanostructured materials based on the
layer-by-layer (LbL) electrostatic nano-assembly of oppositely-charged polyelectrolytes,
which are engineered with bioreceptors to enable label-free detection of target analytes. LbL
biofunctionalization is demonstrated using nanostructured porous silicon (PSi) inter-
ferometers for afﬁnity detection of streptavidin in saliva, through LbL nano-assembly of a bi-
layer of positively-charged poly(allylamine hydrochloride) (PAH) and negatively-charged
biotinylated poly(methacrylic acid) (b-PMAA). High sensitivity in streptavidin detection is
achieved, with high selectivity and stability, down to a detection limit of 600 fM.
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Surface biofunctionalization plays a pivotal role in biosen-sing, when either electrical or optical transducers areexploited, as it imparts to the transducer all the necessary
features for the selective and sensitive detection of the target
analyte. It consists of two chief steps, namely, physico-chemical
surface activation and bioreceptor immobilization, both of which
have a tremendous effect on selectivity and sensitivity of the
resulting biosensor1. In fact, yield and stability of the different
chemical sub-steps of both surface activation and bioreceptor
immobilization processes regulates the number of bioreceptors
available at the transducer surface for unit area (bioreceptor
density) and over time for the biorecognition of the target analyte.
Besides, the bioreceptor orientation might also play a role, par-
ticularly for afﬁnity biosensing, in setting the bioreceptor density
on the surface of the transducer and, in turn, the speciﬁcity/
sensitivity of the biomolecular recognition process2.
For instance, if we focus the attention to biosensing with
optical platforms exploiting silicon-derivative (e.g., Si, SiO2, SiOx)
transducers, the surface activation of the transducer is mainly
carried out through either organosilanization of an oxidized
silicon surface, which leads to the formation of polar, covalent Si-
O-Si bonds between the surface and organosilane molecules, or
by direct hydrosilylation of Si-H surfaces, which results in a self-
assembled monolayer (SAM) of alkyl chains anchored to the
surface through non-polar, covalent Si-C bonds3,4.
Organosilanization undoubtedly represents an attractive
approach, being quite straightforward and relatively cheap.
However, the Si-O-Si bond at the surface is inherently prone to
hydrolysis in aqueous media3,4 and formation of multilayers is
likely to occur due to physisorption of organosilanes onto the
surface5. Both these issues might lead to a progressive change of
the bioreceptor density at the transducer surface over time, which
negatively impacts efﬁciency, stability, and reproducibility of the
whole biofunctionalization process.
On the other hand, the Si-C bond achieved through hydro-
silylation of alkenes and alkynes4,5 features a good stability also in
extreme conditions (e.g., boiling KOH solution, pH= 12)6, thus
providing a very attractive alternative to organosilanization.
However, the metastability of the native Si-H surfaces, which are
prone to oxidation in environmental conditions, and, in turn, the
need of performing the hydrosilylation reaction in an inert,
deoxygenated, and humidity-free atmosphere, has prevented the
popularization of this approach for biosensing.
Generally speaking, the density of bioreceptors available at the
transducers surface is set by both yield γn and number n of the
chemical steps needed to activate the surface and secure the
bonding of the bioreceptor molecules, where the value of γn is
always < 1 (i.e., < 100%) for real processes. Therefore, the yield of
the entire biofunctionalization process γtot might be relatively low
already on ﬂat surfaces being γtot ¼
Qn
1
γn, and it is expected to be
signiﬁcantly lower on nanostructured surfaces, where issues
related to diffusion, steric demand, and orientation of molecules
plays a major role3,4.
The layer-by-layer (LbL) assembly is a pervasive method for
conformal surface coating of substrates with polymers, colloids,
biomolecules, and cells, which offers superior control and ver-
satility with respect to other thin-ﬁlm deposition methods,
especially on micro and nanostructured surfaces7.
Conventional LbL assembly was initially reported by Decher in
19978, who ﬁrstly demonstrated the formation of multilayer
architectures by sequentially adsorbing oppositely charged poly-
electrolytes (i.e., polyanions and polycations) onto a substrate,
through exploitation of enthalpic and entropic driving forces. As
the technique gained interest, a range of interactions, such as
hydrophobic interactions9, hydrogen bonding10, and covalent
coupling11, have been later exploited to prepare multilayered
ﬁlms via LbL assembly. Over the past 20 years, LbL assembly has
been successfully employed for many different applications, from
separation science12,13 to drug delivery14–23, from biomedi-
cine24,25 to biosensing26–29.
As to biosensing, LbL assembly has been mostly used for
electrochemical/enzymatic detection of (bio)molecules. LbL-
based electrochemical/enzymatic biosensors with improved ana-
lytical performance have been reported, thanks to electrostatic
and massive capturing of bioreceptors on charged LbL-coated
surfaces, which does not affect the native conformation of
enzymes, as well as incorporation of metallic nanomaterials in the
polyelectrolytes, which improves the electronic communication
between enzymes and electrodes26.
To our best knowledge, application of LbL assembly to label-
free and afﬁnity optical biosensing has been totally overlooked so
far, because of severe selectivity problems in detecting speciﬁc
binding events of the target analyte with bioreceptors entrapped
in the LbL assembly. This is mostly due to the electrostatic
unspeciﬁc adsorption of both target and interfering biomolecules
onto the charged LbL layers. As a matter of fact, the only two
works that have been reported to date on the use of LbL assembly
for label-free optical biosensing rely on the electrostatic and
unspeciﬁc immobilization of bioreceptors onto the charged
polyelectrolytes of the LbL assembly, either IgG antibodies for the
anti-IgG detection with a ﬁber-optic Fabry-Perot interferometer28
or aptamer-probes for C-reactive protein (CRP) detection with a
lossy-mode-resonance optical ﬁber29. In both cases, no data
were provided to rule out unspeciﬁc electrostatic interaction
between target analytes and charged polyelectrolytes without
bioreceptors.
Among the different materials that have been used for the
preparation of label-free optical biosensors, nanostructured por-
ous silicon (PSi) has been increasingly exploited due to its huge
speciﬁc surface, which allows a tremendous number of molecules
to be accommodated, straightforward fabrication, which allows
high versatility in preparation of optical structures to be achieved,
and low cost, which allows mass production of cheap biosensors
for point-of-care application to be envisaged30. Nonetheless, limit
of detection (LoD) of label-free PSi-based biosensors is bound to
µM–nM concentrations, in spite of transducer architectures (e.g.,
interferometrs31–33, resonant microcavities34,35, rugate ﬁlters36),
surface chemistry (e.g., organosilanization32, hydrosililation36),
bioreceptors (e.g., antibody, aptamer), assay strategy (e.g., pre-
concentration of the target analyte31 recirculation of the target
analyte32), and readout technique (e.g., Fast Fourier Transform
(FFT)30, Interferogram Average over Wavelength (IAW)33). This
can be ascribed to poor yield and reliability of the multi-steps
covalent chemistry functionalization of nanopores (diameter
50 nm) with very high aspect ratio (about 100).
In this work, we report on the surface biofunctionalization of
nanostructured materials via LbL nano-assembly as a robust and
effective alternative route to standard covalent chemistry, e.g.,
organosilanization and hydrosililation, for the development of a
class of afﬁnity biosensors with superior performance.
Surface biofunctionalization via LbL nano-assembly leverages
the electrostatic self-assembly of oppositely charged polyelec-
trolytes, which were engineered to carry bioreceptors covalently
bound to the polymer chain, onto the transducer surface. This
enables tackling the main drawbacks of covalent chemistry when
carried out on nanostructured surfaces, namely, poor control of
molecule nanolayer assembling on the surface, scarce
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07723-8
2 NATURE COMMUNICATIONS |          (2018) 9:5256 | https://doi.org/10.1038/s41467-018-07723-8 | www.nature.com/naturecommunications
reproducibility of the different biofunctionalization steps, low
stability of the bioreceptor immobilization on the surface, low
yield of the overall biofunctionalization process, so improving the
analytical performance of LbL-biofunctionalized biosensors, in
terms of sensitivity, stability, and reproducibility. Further, LbL
biofunctionalization allows selectivity of the bioreceptor-target
binding event to be further boosted by enabling an electrostatic
repulsion between charged LbL assembly and charged non-target
proteins unspeciﬁcally trapped in the LbL assembly. This is
achieved by setting up a repulsive rinsing step at a pH value
signiﬁcantly different from pI values of both target and non-
target proteins, so as to make all proteins charged with the same
polarity of the outer layer of the LbL nano-assembly.
A proof-of-concept demonstration of the superior biosensing
performance of LbL biofunctionalization over silane-based
covalent chemistry is here given using a nanostructured PSi
interferometer for label-free biotin-streptavidin afﬁnity
biosensing.
LbL biofunctionalization of PSi interferometers enables the
preparation of stable and reliable label-free optical biosensors
with a LoD for streptavidin of 600 fM, which is about ﬁve orders
of magnitude (i.e., 105) lower than that achieved on control PSi
interferometers prepared with silane-based chemistry (about 100
nM). This also represents a 300-fold improvement with respect to
the state-of-the-art on PSi biosensors, both in terms of LoD and
sensitivity, pushing analytical performance of label-free PSi bio-
sensors to that of the most sensitive label-free biosensing plat-
forms, namely surface plasmon resonance (SPR), local surface
plasmon resonance (LSPR), interferometers, ring resonators,
photonic crystals, optical ﬁbers, as highlighted in Fig. 1.
Remarkably, stability and efﬁcacy of LbL biofunctionalization
was successfully conﬁrmed in a complex and non-ﬁltered body
ﬂuid spiked with streptavidin, namely saliva, which is a largely
available and easily accessible non-invasive body ﬂuid of
increasing interest for bioclinical assays.
Results
LbL biofunctionalization of PSi interferometers. Electro-
statically driven LbL biofunctionalization of PSi interferometers
for biotin/streptavidin afﬁnity biosensing was carried out as
sketched in Fig. 2a. Oxidized PSi interferometers were prepared
through a two-step electrochemical etching of crystalline silicon
wafers and subsequent thermal oxidation (Fig. 2a-1). A ﬁrst PSi
sacriﬁcial layer was produced through anodic etching and
immediately dissolved by alkaline etching to provide the silicon
surface with a nanostructured texture with tiles of average size of
50 nm33. A PSi interferometer with thickness of ~5 µm, porosity
of ~80%, and pore size of ~50 nm (aspect ratio of 100) was next
produced through anodic etching of the so-textured silicon sub-
strate (Figs. 2b, c and Supplementary Figure 2a, b). The as-
prepared PSi interferometer was subjected to thermal oxidation to
convert silicon to silicon dioxide, so as to achieve a hydrophilic,
negatively charged surface that was functional to carry out an
electrostatically driven LbL coating of the PSi surface. Drop
casting of a positively charged polyelectrolyte, namely poly(ally-
lamine hydrochloride) (PAH), solution onto the oxidized PSi
interferometer, resulted in the conformal electrostatic adsorption
of a PAH nanolayer (a few nm37,38) onto the inner surface of the
nanopores (Fig. 2a-2). Eventually, drop casting of a biotinylated
negatively charged polyelectrolyte, namely biotinylated poly
(methacrylic acid) (b-PMAA), solution onto the PAH-coated PSi
interferometer, resulted in the conformal electrostatic adsorption
of a b-PMAA nanolayer onto the PAH, thus achieving a single bi-
layer of PAH/b-PMAA with bioreceptors directly bonded to the
external PMAA polyelectrolyte (Fig. 2a-3).
Optical characterization of the PSi interferometers through UV
−Vis FFT reﬂectance spectroscopy (FFT-RS) showed a consistent
variation of the optical thickness (effective optical thickness
(EOT)= 2nefft, with neff effective refractive index and t thickness
of the PSi interferometer) at the different preparation steps
(Supplementary Figure 1c,d). The results are summarized in
Fig. 1d. Speciﬁcally, the EOT values of as-prepared PSi
interferometers (13,934 ± 490 nm, calculated from reﬂectance
spectra acquired in air) decreased after thermal oxidation
(reduction of −1177 ± 160 nm) due to partial conversion of
silicon to silicon dioxide, then consistently increased (with respect
to oxidized PSi interferometers) upon electrostatic LbL-coating of
PAH (111 ± 50 nm) and b-PMAA (390 ± 157 nm). The effective
refractive index (neff) of the PSi interferometers (average
thickness of 4.92 µm) lowered from 1.416 Refractive Index Unit
(RIU) for the as-prepared PSi interferometer to 1.296 RIU after
oxidation, and then increased to 1.301 RIU after PAH coating
and 1.332 RIU after b-PMAA coating.
To check homogeneity of LbL assembly over the entire depth
of PSi interferometers, we inﬁltrated an oxidized PSi interferom-
eter with a sulfo-rhodamine-labeled PAH (a red-emitting
ﬂuorescent dye), as well as a PSi interferometer previously coated
with non-labeled PAH with a ﬂuorescein-labeled PMAA (a green-
emitting ﬂuorescent dye), using the deposition protocol pre-
viously described. Figures 2e-1 and 2e-2 show bright-ﬁeld and
ﬂuorescence optical microscopy images, respectively, of the cross-
section of a PSi interferometer inﬁltrated with sulfo-rhodamine-
labeled PAH; Fig. 2e-3 shows the cross-section of a PSi
interferometer, previously coated with non-labeled PAH, after
inﬁltration of ﬂuorescein-labeled PMAA. Negative control
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Fig. 1 State-of-art plasmonic and photonic platforms for high-sensitivity
label-free biosensing. For each platform, namely SPR54, LSPR55,
interferometer56,57, ring resonator58, photonic crystal59, optical ﬁber60, the
best-performing biosensor exploiting nanostructured materials is indicated
with an asterisk, when available. Porous silicon (PSi) nanostructured
biosensors performed less well than the other platforms to date, at least in
terms of sensitivity and, in turn, limit of detection (LoD). The LbL
biofunctionalization of nanostructured materials proposed in this work
allows the gap between PSi optical biosensors and other optical biosensing
platforms to be ﬁlled, thus pushing PSi biosensors to minimum detectable
analyte concentrations comparable to those of the best-performing label-
free biosensing platforms
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ﬂuorescence images of oxidized PSi interferometers both bare
(Supplementary Figure 2a, b) and coated with PAH/PMAA
(Supplementary Figure 2c, d) are reported as Supplementary
Information. From ﬂuorescence images, it is apparent that the
pores are uniformly covered with both the polyelectrolytes all
over their depth, in spite of their nanometric diameter (50 nm in
average) and high aspect ratio (about 100).
A chief advantage of LbL biofunctionalization via charged
polyelectrolytes, with respect to covalent chemistry, concerns the
electrically induced self-regulation of the thickness of both single
and multilayer ﬁlms, which turns into a superior homogeneity
and reproducibility of LbL ﬁlms when deposited within high
aspect ratio nanostructures (e.g., nanopores), where constrained
diffusion of molecules might lead to a reduction of the
concentration with depth and, in turn, to non-homogeneous
surface coating37. The thickness is few nm per layer regardless of
the substrate used and increases linearly with the number of
layers deposited, which makes the ﬁlm properties highly
controllable and rather independent of the substrate. The
polyelectrolyte thickness and conformation at the surface and,
in turn, the newly created ﬁlm surface is thus mostly dependent
on the chosen polyelectrolytes and adsorption conditions, and
less dependent on the substrate or the substrate charge density38.
Moreover, the use of polyelectrolytes for surface biofunctiona-
lization, rather than organo-linkers as in covalent chemistry, is
advantageous in terms of good adhesion of the nanolayer to the
underlying substrate, because polymers can bridge over under-
lying defects. In fact, the electrostatic attraction between
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Fig. 2 Layer-by-Layer biofunctionalization of nanostructured PSi interferometers. a Sketch of the biofunctionalization of the nanostructured surface of PSi
interferometers via LbL nano-assembly: (1) preparation and oxidation of PSi interferometers (gray, negatively charged); (2) PAH coating (green, positively
charged) of oxidized PSi interferometers; (3) b-PMAA (biotinylated PMMA) coating (red, negatively charged) of PSi/PAH interferometers. Details of the
chemical structure of the polyelectrolytes used for LbL assembly, namely PAH (green circle) and PMAA (red circle), and of biotin (violet triangle)
covalently linked to PMAA by amino-coupling, are given at the bottom of a. b SEM top-view image (50,000 ×magniﬁcation) of the PSi interferometer
surface (scale bar is 1.00 µm). The inset shows a higher magniﬁcation SEM image (200,000 ×magniﬁcation) of the PSi surface that allows pore
arrangement and size to be clearly appreciated (scale bar is 100 nm). c SEM cross-section image (25000 ×magniﬁcation) of the PSi interferometer
highlighting the columnar structure of the pores (scale bar is 1.00 μm). The inset shows a histogram of the pore size distribution, highlighting an average
diameter of about 55 nm. d EOT-EOTox values recorded for PSi interferometers both as-prepared and after each LbL biofunctionalization step. The EOT
value of oxidized PSi interferometers (i.e., EOTox) is used as reference to obtain positive differential EOT values. Data are provided as average values over
seven replicates with error bars representing one standard deviation. e Bright-ﬁeld optical image (1) and ﬂuorescence images (2, 3) of the cross-section of
oxidized PSi interferometers LbL-coated with (2) sulfo-rhodamine-labeled PAH and with (3) ﬂuorescein-labeled PMAA on top of non-labeled PAH coating
(scale bar is 15 µm). The homogeneity of the electrostatically driven LbL coating can be easily appreciated by the uniform ﬂuorescence emission of the
labeled polyelectrolytes over the whole PSi thickness
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oppositely charged molecules for multilayer formation has shown
to have the least steric demand of all chemical bonds24.
Conversely, covalent chemistry biofunctionalization (either
silanization or hydrosylilation) is restricted to certain classes of
organics that give rise to self-assembled multilayer architectures,
e.g., organo-linker/linking-molecule/bioreceptor, of poor quality
and with scarce reliability3,4. These problems are likely caused by
the high steric demand of covalent chemistry and the severely
limited number of reactions with exactly 100% yield, which is a
prerequisite for the preservation of functional group density in
each layer24.
A further major advantage of LbL biofunctionalization from
polyelectrolyte solution is that different building-blocks, e.g.,
bioreceptors, can be incorporated in individual ﬁlms and that
difﬁcult-to-control (unreliable) chemical steps, e.g., coupling of
bioreceptors, can be determined in solution, before going to
the nanostructured surface. In addition, the multilayer architec-
ture is completely determined by the deposition sequence24. This
leads to a controlled and uniform distribution of bioreceptors
over the coated surface, which would allow both design and
performance of biosensors built using LbL nano-assembly to be
signiﬁcantly improved with respect to those achieved with the
standard chemistry counterpart.
Stability of LbL assembly with pH and ionic strength. A major
issue when dealing with surface biofunctionalization for sensing
purposes is reliability and stability of the multilayer ﬁlm depos-
ited on the surface itself, which, if poor, would result in an
inefﬁcient surface coverage and loss of bioreceptors3,4.
Stability of LbL assembly was assessed in the presence of three
different buffers, commonly used for bioassays and featuring
different pH and ionic strength I values, namely, acetate buffer
(10 mM CH3COOH/CH3COONa with 100 mM NaCl, I= 0.106
M, pH= 5); phosphate-buffered saline (PBS) buffer (100 mM
NaH2PO4/Na2HPO4 with 100 mM NaCl, I= 0.36, pH= 7.4);
and, HEPES buffer (10 mM with HEPES with 100 mM NaCl, I=
0.103, pH= 7.4).
The LbL-biofunctionalized PSi interferometers were secured
into a ﬂow cell and stability was investigated through FFT
reﬂectance spectroscopy, which allows refractive index variation
due to deterioration of the LbL assembly to be reliably detected.
The EOT value was continuously monitored over time for 80 min
(at least) upon inﬁltration of the ﬂow cell with the buffers at 100
µL min−1.
Excellent stability of the EOT signal over time was recorded in
acetate buffer (EOT-EOT0=−3.8 ± 12.6 nm, average value and
standard deviation over 80 min, where EOT0 is the reference
value at t = 0) (Supplementary Figure 3a), clearly demonstrating
that the LbL assembly is very stable at such pH and ionic strength
conditions. Inﬁltration of HEPES buffer (same ionic strength and
higher pH compared with acetate), after stabilization in acetate
buffer, led to a small variation of the EOT signal that is
compatible with the refractive index change between HEPES and
acetate buffers (Fig. 3a). Remarkably, the EOT signal was well
stable in HEPES (EOT-EOT0=−11.9 ± 1.6 nm, average value
and standard deviation over 30 min) and went back to the
baseline value once acetate was inﬁltrated back in the ﬂow cell.
This clearly indicates that the LbL assembly is stable at such a
higher pH value (namely 7.4), at low ionic strength. Eventually,
inﬁltration of PBS buffer in the ﬂow cell, after stabilization in
acetate buffer, led to an abrupt, major blue-shift of the EOT
signal, with respect to the value in acetate, which is not
compatible with the variation of the refractive index between
PBS and acetate buffers, followed by an important drift over time
(Supplementary Figure 3b). Once acetate buffer was further
inﬁltrated in the ﬂow cell the EOT signal did not go back to the
baseline value, thus indicating that an irreversible change of the
LbL assembly occurred in PBS. We argue that the higher ionic
strength of PBS (I= 0.36), with respect to that of both acetate and
HEPES buffers (about 0.1), weakens the electrostatic interactions
between SiO2, PAH, and PMAA charged layers, thus promoting
the LbL multilayer de-assembly. Figure 3b summarizes the results
on the stability of the LbL nano-assembly in acetate, PBS, and
HEPES buffers. The disruption of the LbL assembly in PBS is
apparent from the strong and irreversible change of the EOT
value after inﬁltration of PBS in the LbL-coated PSi
interferometers.
Optimizing speciﬁc/unspeciﬁc binding with repulsive rinsing.
In spite of the extensive use of electrostatic LbL assembly for
electrochemical/enzymatic biosensing, its use in afﬁnity optical
and afﬁnity biosensing is still in its infancy26,27. In fact, the
intrinsic unspeciﬁc interaction between charged coating layers
and oppositely charged either target bioanalytes (in the absence of
bioreceptors) or interfering analytes (in the presence of bior-
eceptors) has posed severe limitations so far.
The minimization of unspeciﬁc adsorption is here successfully
achieved leveraging a rinsing step that ensures electrostatic
repulsion between the LbL assembly and both target analyte and
interfering biomolecules that are not speciﬁcally bound to the
bioreceptors. The repulsive rinsing step ensures that only the
target analytes that are speciﬁcally bound to their biorepceptors
will be retained after rinsing. Conversely, any of the analytes
(both target and interfering) that are unspeciﬁcally trapped in the
outer polyelectrolyte layer of the LbL assembly will be removed
during the rinsing step by repulsive electrostatic forces established
between polyelectrolyte and biomolecules electrically charged
with same polarity. Figures 3c, e show a sketch of speciﬁc target
binding and unspeciﬁc repulsive rinsing for biofunctionalized and
control LbL-coated interferometers, respectively.
To assess minimization of unspeciﬁc adsorption through
repulsive rinsing, we prepared PSi interferometers coated with
both PAH and either biotinylated b-PMAA (biotin:PMAA
monomer= 1:30) or non-biotinylated PMAA (as control). Notice
that the outer PMAA layer of the LbL assembly is negatively
charged regardless of the biotinylation. The target analyte was
streptavidin, and interfering biomolecules taken into account
were pepsin and bovine serum albumin (BSA). Streptavidin is
globally neutral at pH= pIstrept= 5.0 and deeply shielded by a
relatively high ionic strength (NaCl 100 mM). To minimize
protein–protein ionic repulsion and improve, in turn, streptavi-
din diffusion inside the nanopores39, we used acetate buffer (pH
= 5.0) with 100mM of NaCl as running buffer. On the other
hand, BSA and pepsin have an isoelectric point of pIBSA= 4.7 and
pIpepsin= 1, respectively. Therefore, in order to yield both target
and interfering biomolecules negatively charged in the rinsing
step and enable, in turn, electrostatic repulsion between
unspeciﬁcally bound biomolecules and PMAA, we used HEPES
(pH= 7.4 > pIBSA, pIpepsin, pIstrept) as a rinsing buffer.
The IAW reﬂectance spectroscopy (IAWRS) was used for the
real-time monitoring of the interactions (speciﬁc and unspeciﬁc)
of both b-PMAA and PMAA with streptavidin, pepsin, and BSA.
The IAWRS was here preferred to FFT-RS as the former
guarantees both higher sensitivity and greater reproducibility
with respect to the latter33,40, enabling the reliable measurement
of concentrations below the nM level, which would not be
otherwise appreciable using FFT-RS.
Acetate was initially injected in the ﬂow cell for 40 min to
ensure IAW signal stabilization (Phase 1), then streptavidin at
500 µg mL−1 (i.e., ~ 8.3 µM) was inﬁltrated at 5 µL min−1 for 40
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min (Phase 2). The IAW signal increased to ~0.7 a.u., with respect
to the IAW0 reference value in acetate, for the LbL-
biofunctionalized interferometers (Fig. 3d), whereas for the
control interferometers it only increased to ~0.25 a.u. (Fig. 3f).
We argue that the 3× increase in the IAW variation of
biofunctionalized interferometers, with respect to control
interferometers, is a clear indication that streptavidin–biotin
afﬁnity binding occurred in the former. On the other hand,
unspeciﬁc adsorption of streptavidin in the PMAA network is
responsible for the signal increase in the latter. In fact, the rinsing
step in acetate (40 min at 100 µL min−1) clearly shows that the
IAW signal of biofunctionalized interferometers stabilizes
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Fig. 3 Stability and speciﬁcity of LbL biofunctionalization. a Sensorgram (EOT-EOT0 vs. time) recorded on LbL-biofunctionalized PSi interferometers
highlighting high stability of the LbL nano-assembly both in acetate and HEPES buffers. b EOT-EOT0 values acquired on LbL-biofunctionalized PSi
interferometers upon continuous inﬁltration of acetate buffer, as well as in acetate buffer before and after injection of PBS and HEPES buffers. Data are
provided as average values of EOT-EOT0 ﬂuctuations over time (data points >30) with error bars representing one standard deviation. c Sketch of the inner
surface of PSi interferometers LbL-biofunctionalized with PAH/b-PMAA (1), highlighting afﬁnity (speciﬁc) binding of streptavidin with biotin (2) and
repulsive rinsing of streptavidin unspeciﬁcally adsorbed (electrostatic interaction) on b-PMAA (3). d Sensorgram (IAW-IAW0 vs. time) acquired on LbL-
biofunctionalized PSi interferometers upon injection of streptavidin 8.3 µM: signal stabilization in acetate buffer (step 1); injection of streptavidin and
afﬁnity interaction of streptavidin with b-PMAA (step 2); repulsive rinsing in HEPES buffer and removal of streptavidin unspeciﬁcally adsorbed on b-PMAA
(step 3). Acetate buffer is eventually injected to allow a direct comparison of the IAW values before streptavidin injection and after repulsive rinsing to be
feasible. e Sketch of the inner surface of PSi interferometers LbL-coated with bare PAH/PMAA (non-biotinylated) (1), showing unspeciﬁc interaction of
streptavidin with PMAA (2) and complete removal of streptavidin unspeciﬁcally adsorbed on PMAA by repulsive rinsing (3). f Sensorgram (IAW-IAW0 vs.
time) acquired on PSi interferometers LbL-coated with bare PAH/PMAA (non-biotinylated) upon injection of streptavidin 8.3 µM (steps 1 through 3 as in
d). g IAW-IAW0 values measured on LbL-biofunctionalized PSi interferometers upon injection of 8.3 µM streptavidin (target molecule), as well as 14 µM
Pepsin and 7.6 µM BSA (non-target molecules), highlighting that a high speciﬁcity is achieved through repulsive rinsing. Data are provided as average
values over 3 replicates with error bars representing one standard deviation
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without appreciable reduction over time, whereas a slight
decrease is observed for control interferometers due to partial
removal of streptavidin unspeciﬁcally trapped in the PMAA
layer. The next repulsive rinsing step in HEPES (40 min at
100 µL min−1, Phase 3) fully removes streptavidin that is
unspeciﬁcally bound to the PMAA network through electrostatic
repulsion of proteins now charged with same polarity as the
PMAA layer. This is apparent for control interferometers (Fig. 3f),
where the IAW signal quickly and signiﬁcantly decreases after
HEPES injection, thus demonstrating that the repulsive rinsing
allows most of the streptavidin unspeciﬁcally bound to PMAA to
be removed. Remarkably, by further injecting acetate (reference
buffer, 40 min at 100 µLmin−1) it is feasible to directly compare
(i.e., in the same buffer) IAW values before streptavidin injection
and after repulsive rinsing, from which a negligible residual
unspeciﬁc signal is visible for control interferometers, namely
IAW-IAW0= 0.028 ± 0.005 a.u over three replicates. On the
other hand, for the biofunctionalized interferometers the IAW-
IAW0 value does not signiﬁcantly change after rinsing, conﬁrm-
ing that the streptavidin is speciﬁcally bound to bioreceptors in
this case (Fig. 3d). Notice that, the change of the IAW value with
HEPES in Figure 3d can be mainly ascribed to a change in the
refractive index between HEPES and acetate buffers.
To further corroborate the validity of the repulsing rinsing step
in HEPES, unspeciﬁc interaction between the LbL assembly
(PAH/PMAA) and non-target proteins, namely pepsin and BSA,
was investigated. Notice that BSA represents a worst case, being
BSA a protein commonly employed in surface passivation due its
ability to effectively and unspeciﬁcally adsorb to materials (even
nanostructured). The results are summarized in Fig. 3g. Injection
of pepsin and BSA at 500 µg mL−1 (i.e., ~ 14 µM for pepsin and
~7.6 µM for BSA) resulted in an IAW-IAW0 signal of 0.033 ±
0.014 and 0.401 ± 0.064 a.u., respectively (Supplementary Fig-
ure 3c,d), both of which are signiﬁcantly smaller than the value
recorded for the speciﬁc biding of streptavidin (i.e., 0.8 a.u.).
Remarkably, pepsin is almost fully removed from PMAA
(speciﬁcity ratio between streptavidin and pepsin ~ 35 and
IAW-IAW0 comparable to the value recorded for the selective
binding of streptavidin 8.3 pM, i.e., 0.031 ± 0.006 a.u., see next
paragraph). Moreover, in spite of the relatively high IAW-IAW0
value achieved for BSA, the sensorgram recorded for BSA
(Supplementary Figure 3d) clearly shows that the removal
efﬁciency of BSA unspeciﬁcally adsorbed on PMAA is nearly
60%, which is roughly the same of that achieved using a
denaturation solution of 0.5% sodium dodecyl sulfate in aqueous
solution41.
Biosensing with LbL-biofunctionalized PSi interferometers.
Three PMAA polyelectrolytes with different degrees of biotiny-
lation, namely, biotin:PMAA monomer= 1:65, 1:40, and 1:30,
were prepared to investigate how the biotinylation degree impacts
the sensing performance of PSi interferometers. Regardless of the
biotinylation degree, speciﬁc binding of streptavidin at con-
centration of 8.3 µM (i.e., 500 µg mL−1) was tested according to
the injection/rinsing protocol described above. Figure 4a sum-
marizes the IAW-IAW0 values obtained upon injection of
streptavidin 8.3 µM using PMAA with different biotinylation
degrees; nonspeciﬁc IAW-IAW0 value recorded at the same
streptavidin concentration for bare (i.e., non-biotinylated) PMAA
is also reported. The sensorgrams of the IAW-IAW0 signals
recorded for the different biotinylation degrees are provided in
Fig. 3d for PMAA 1:30, and in Supplementary Figure 4a,b for
PMAA 1:65 and 1:40, respectively. The IAW-IAW0 signal, due to
speciﬁc binding of streptavidin and biotin, recorded for b-PMAA
at the smallest biotinylation degree is one order of magnitude
higher (10×) than that recorded for bare PMAA. Moreover, it
increases signiﬁcantly with the degree of biotinylation of the
PMAA (Fig. 4a, Supplementary Figure 4c). These results envisage
the possibility of further increasing the IAW-IAW0 output signal
of LbL-biofunctionalized biosensors by increasing the biotinyila-
tion degree of PMAA, to some extent at least.
Evaluation of the analytical performance of LbL-
biofunctionalized PSi interferometers was carried out using
PMAA with biotinylation degree 1:30, at streptavidin concentra-
tions ranging from 0.5 ng mL−1 (~ 8.3 pM) to 500 µg mL−1
(~8.3 µM).
Figure 4b shows the calibration curve, namely, IAW-IAW0 vs.
streptavidin concentration in the range 8.3 pM to 8.3 µM,
achieved over three different PSi interferometers functionalized
with b-PMAA(1:30) (red dots, log-log scale). A magniﬁcation of
the calibration curve in the region 8.3 pM to 8.3 nM is reported in
Fig. 4c in linear scale, where the higher sensitivity of the
interferometer at the smaller concentrations, with respect to
higher ones, can be better appreciated. The gray area indicates the
region were the IAW-IAW0 signal is below 3.3σIAW0 value, being
σIAW0 = 0.004 a.u. the standard deviation of the IAW0 reference
signal (no streptavidin) measured over three replicates. A power-
law trend encompassing the whole range of concentrations tested
is apparent from Fig. 4b, which is best-ﬁtted (R2= 0.98) with the
following equation (red solid trace):
IAW IAW0 ¼ 0:070 ´C0:227 ð1Þ
where C is the concentration of the streptavidin expressed in nM.
All the tested concentrations are well discriminated with
respect to the noise ﬂoor with excellent signal-to-noise ratio
(SNR), namely, SNR= 212 for 8.3 µM and 7.5 for 8.3 pM.
Figure 4d shows the typical sensorgram (raw data) acquired for
the lowest tested streptavidin concentration (i.e., 8.3 pM), high-
lighting that a stable signal can be measured at such a small
concentration over the noise level. The biosensor reproducibility
evaluated over the whole concentration range is satisfying,
especially considering the extremely low concentrations tested
(average coefﬁcient of variation %CVav= 25%, n= 3).
Figure 4e shows bright-ﬁeld (1) and ﬂuorescence (2, 3) optical
microscopy images of the cross-section of a LbL-
biofunctionalized PSi interferometer after injection of 83 nM
and 8.3 µM streptavidin labeled with sulfo-rhodamine. Control
images are shown in Supplementary Figure 2. By comparison of
ﬂuorescence and bright-ﬁeld images, it is apparent that binding of
streptavidin uniformly occurs throughout the whole PSi thick-
ness, both at the lower and the higher concentrations tested by
ﬂuorescence measurements. Negative control ﬂuorescence images
of bare (i.e., non-labeled) 8.3 µM streptavidin binding are shown
in Supplementary Figure 2e,f.
A theoretical LoD is calculated from the calibration curve by
extrapolation of the concentration corresponding to the IAWLo-
D−IAW0 value for which SNR= 3.3σIAW0= 0.013 a.u., which gives
rise to a minimum detectable concentration of 6 × 10−4 nM (i.e.,
600 fM). This is well consistent with the value obtained using the
formula: LoD= 3.3σIAW0/S= 2.6 × 10−4 nM (i.e., 260 fM), being
S= 49.16 nM−1 the sensitivity of the PSi biosensor around a
streptavidin concentration of 600 fM.
To the best of our knowledge, this is the lowest detected
concentration using PSi as transducer in label-free and afﬁnity
biosensing since the ﬁrst seminal Sailor group research paper, in
which fM concentrations were detected exploiting charge-carrier
mobilization induced by biomolecular complexation during the
afﬁnity bindings42.
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To fairly assess advantages of the LbL biofunctionalization
strategy for biosensing applications with respect to covalent
functionalization chemistry (i.e., organosilane chemistry),
we prepared a biotinylated PSi interferometer (as control)
using (3-aminopropyl)triethoxysilane (APTES) as linker
between the oxidized surface of PSi and biotin 3-sulfo-N-
hydroxysuccinimide ester sodium salt. Effectiveness of covalent
biofunctionalization was veriﬁed step-by-step using EOT
reﬂectance spectroscopy (Supplementary Figure 5). Biotiny-
lated control interferometers were then tested for streptavidin
detection in the range of concentration 8.3 pM to 8.3 µM, using
IAWRS.
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Fig. 4 High-sensitivity biosensing with LbL-biofunctionalized PSi interferometers. a IAW-IAW0 values recorded on LbL-biofunctionalized PSi
interferometers upon afﬁnity interaction with 8.3 µM streptavidin with b-PMAA at different biotinylation degrees, namely 1:65, 1:40, and 1:30. The IAW-
IAW0 value recorded on PSi interferometers LbL-coated with bare PAH/PMAA (non-biotinylated) due to unspeciﬁc adsorption of 8.3 µM streptavidin is
also reported. b Calibration curve (IAW-IAW0 vs. streptavidin concentration, log-log scale) of LbL-biofunctionalized PSi interferometers coated with b-
PMAA (1:30) (red dots) for streptavidin concentration in the range 8.3 pM−8.3 µM; data are best-ﬁtted with a power law (red solid trace). The calibration
curve of PSi interferometers biofunctionalized using silane-based chemistry is also reported (green triangles). The gray region represents the 3.3σIAW0
noise level recorded in acetate buffer. cMagniﬁcation of the calibration curves in b for streptavidin concentration in the region 0–10 nM (linear scale). Data
in a-c are provided as average values over three replicates with error bars representing one standard deviation. d Sensorgram (IAW-IAW0 vs. time)
acquired on LbL-biofunctionalized PSi interferometers coated with b-PMAA (1:30), showing speciﬁc detection of streptavidin 8.3 pM (i.e., the lowest tested
concentration): signal stabilization in acetate buffer (step 1); injection of streptavidin and afﬁnity interaction of streptavidin with b-PMAA (step 2);
repulsive rinsing in HEPES buffer and removal of streptavidin unspeciﬁcally adsorbed on b-PMAA (step 3). e Bright-ﬁeld (1) and ﬂuorescence (2, 3) images
of the cross-section of the oxidized PSi interferometer LbL-coated with PAH/b-PMAA after afﬁnity binding of 83 nM (2) and 8.3 µM (3) sulfo-rhodamine-
labeled streptavidin (scale bar is 15 µm). f Sensorgrams (IAW-IAW0 vs. time), acquired on LbL-biofunctionalized PSi interferometers coated with b-PMAA
upon consecutive injections of diluted saliva spiked with 83, 830, and 8300 nM of streptavidin. g Sensorgram (IAW-IAW0 vs. time) of the injection of
diluted saliva spiked with streptavidin 83 nM, highlighting the different injection steps. h Bar graph of IAW-IAW0 signals acquired after injection of diluted
saliva spiked with streptavidin 83, 830, and 8300 nM. Data are provided as average values of IAW-IAW0 ﬂuctuations over time (data points= 30) with
error bars representing one standard deviation
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Figure 4b (green triangles) shows the calibration curve
achieved for the PSi interferometer prepared using covalent
chemistry, superposed to that achieved using LbL biofunctiona-
lization. In this case, only streptavidin concentrations >83 nM are
above the noise region (gray area in Fig. 4b), so that they are
reliably detected. These concentrations are at least ﬁve orders of
magnitude higher than those measured using LbL-
biofunctionalized interferometers. Notice that, the noise level of
the IAW0 value measured for the control interferometer is
3.3σIAW0= 0.017 a.u., which is statistically equal to that obtained
for LbL-biofunctionalized interferometers, i.e., 0.013 a.u.
These experimental results conﬁrm that LbL biofunctionaliza-
tion produces a signiﬁcant improvement of the analytical
performance of optical label-free PSi biosensors, in terms of
sensitivity and LoD, at least, compared with that achieved using
the commonly employed covalent silane chemistry.
Assessment of LbL-biofunctionalized PSi interferometers in
saliva. Stability and effectiveness of LbL biofunctionalization is
eventually tested in a real and complex human matrix, namely
non-ﬁltered saliva. Saliva is an exocrine and oral ﬂuid secretion
that is attracting increasing attention in clinical chemistry and
forensic toxicology being a well-established and non-invasive
alternative to serum and plasma43.
The chemical composition of saliva consists of 99.5% water and
0.5% solid components, roughly. The solid components consist,
in turn, of 0.1% electrolytes (i.e., calcium, magnesium, sodium,
potassium, chloride, bicarbonate, phosphate), 0.3% proteins (i.e.,
enzymes, IgG, IgA, antimicrobial factors, mucosal glycoproteins,
albumin, polypeptides, oligopeptides), and for the remaining
0.1% of small organic molecules derived from metabolic activity
(i.e., glucose, citrate, lactate, ammonia, urea, uric acid creatinine
cholesterol and cyclic adenosine monophosphate)44. In addition,
saliva also contains buccal epithelial cells and blood leukocytes45.
Saliva samples (1-2 mL) collected from a volunteer were
immediately vacuumed, then diluted 1:10 in acetate buffer (i.e.,
the running/binding buffer of this work). Dilution has the twofold
aim of: (1) reducing the concentration of solid components,
namely proteins and small organic molecules, from 0.4% (i.e.,
4000 µg mL−1) to 0.04% (i.e., 400 µg mL−1), to yield it compar-
able to the highest concentration of biomolecules tested in acetate
buffer, namely 500 µg mL−1 of streptavidin, pepsin, and BSA; (2)
decreasing saliva viscosity, to reduce possible ﬂuidics (e.g.,
microchannel clogging) and optical (e.g., unwanted refractive
index changes) effects induced by a highly concentrated solid
compound and cells. The diluted saliva (without any further
ﬁltration or puriﬁcation) is either directly used for evaluation of
the stability of LbL-biofunctionalized PSi interferometers or
spiked with streptavidin at concentrations of 83, 830, and 8300
nM to evaluate its selective detection in a complex body ﬂuid.
Stability of the LbL nano-assembly in saliva is investigated in
terms of changes in the EOT value in acetate buffer of LbL-coated
PSi interferometers upon injection of saliva at 5 µL min−1 for 40
min, using the same injection protocol described for BSA and
pepsin control experiments (see section Optimizing speciﬁc/
unspeciﬁc binding with repulsive rinsing). The LbL-
biofunctionalized PSi interferometers were secured into a ﬂow
cell and stability was investigated through FFT reﬂectance
spectroscopy, which allows refractive index variation due to
deterioration of the LbL assembly to be reliably detected
(Supplementary Figure 6a). EOT-EOT0 values recorded before
(i.e., 0.08 ± 2.98 nm) and after (i.e., − 4.1 ± 5.6 nm) injection of
saliva (over three replicates, in acetate buffer) conﬁrm a good
stability of the LbL nano-assembly. Indeed, the EOT changes mea-
sured in saliva are not statistically different (Student's t-test
conﬁdence level= 99%) from that recorded injecting only acetate
buffer over 80 min (EOT-EOT0=−3.8 ± 12.6 nm, Fig. 3b).
To better quantify unspeciﬁc adsorption of solid components
of saliva on the LbL-biofunctionalized PSi interferometers,
IAWRS was used to analyze the reﬂectance spectra upon saliva
injection over time, as it allows a higher sensitivity with respect to
FFT reﬂectance spectroscopy to be achieved40. Supplementary
Fig. 6b shows the typical sensorgram (i.e., IAW-IAW0 vs. time)
recorded for saliva using IAWRS, from which it is apparent that
biomolecules (present in saliva) unspeciﬁcally adsorbed on the
LbL coating after saliva injection are efﬁciently removed through
the repulsive rinsing step in HEPES buffer. Remarkably, the
residual IAW value (in acetate buffer) after saliva injection (i.e.,
IAW-IAW0= 0.090 ± 0.013 a.u.) is smaller than that achieved
with BSA and only three times that measured for pepsin, at about
same concentration. This is an important result, especially
considering both complexity and heterogeneity of saliva, which
contains about 400 µg mL−1 (after 1:10 dilution) of biomolecules
and small organic molecules derived from metabolic activity, in
addition to cells. Notice that, the use of diluted saliva does not
produce signiﬁcant oscillations of the IAW signal in acetate buffer
after the rinsing step (i.e., noise level after saliva injection and
rinsing σIAW= 0.004 a.u., which is the same value achieved
injecting only acetate buffer, namely σIAW0).
Analytical performance of the LbL-biofunctionalized PSi
interferometers in saliva spiked with 83, 830, and 8300 nM of
streptavidin are then evaluated using the same protocol described
above. Figure 4f shows the sensorgram recorded for three
consecutive injections of saliva spiked with 83, 830, and 8300
nM streptavidin, which clearly highlights that all the tested
streptavidin concentrations are well discriminated in saliva.
Remarkably, the IAW signal monotonically increases as the
streptavidin concentration in saliva increases, reaching IAW
values (measured after the repulsive rinsing in HEPES) compar-
able to those achieved in acetate buffer at the same streptavidin
concentrations (see Fig. 4b). IAW-IAW0 values recorded for 83,
830, and 8300 nM streptavidin in saliva using LbL-
biofunctionalized PSi interferometers are summarized in Fig. 4h.
A detailed view of the sensorgram recorded for saliva spiked with
83 nM streptavidin is shown in Fig. 4g. Conversely to what
happens in blank saliva (with no streptavidin), during the injec-
tion of saliva spiked with streptavidin the IAW value shows
noticeable oscillations and the adsorption kinetics results to be
faster than in blank saliva. Nonetheless, the signal-to-noise ratio
of the IAW signal measured in acetate buffer after injection of
either blank or streptavidin-spiked saliva remains unchanged. We
argue that, in the presence of streptavidin, competitive processes
occur at the LbL nano-assembly between faster speciﬁc binding of
streptavidin with biotin and slower unspeciﬁc binding of
interfering biomolecules, present in saliva, with PMAA. This is
consistent with the reduction of both IAW oscillations and IAW
unspeciﬁc signal as the streptavidin concentration in
saliva increases.
Discussion
In this work, LbL biofunctionalization of nanostructured mate-
rials by self-assembling of oppositely charged polyelectrolytes
engineered with suitable bioreceptors is successfully demon-
strated as a robust and effective alternative route to covalent
chemistry towards the development of optical label-free afﬁnity
biosensors with improved performance, in terms of sensitivity
and selectivity. In particular, high sensitivity is enabled through
self-regulated deposition of a conformal and stable nano-
assembly featuring a prescribed density of bioreceptors; on the
other hand, a repulsive rinsing step removing most of the
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07723-8 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:5256 | https://doi.org/10.1038/s41467-018-07723-8 | www.nature.com/naturecommunications 9
biomolecules unspeciﬁcally bound to the nano-assembly allows a
high selectivity to be achieved.
The proof-of-concept demonstration is given on a nanos-
tructured PSi interferometer, which was employed for the
development of a label-free biotin–streptavidin afﬁnity bionsen-
sor. LbL biofunctinalization is shown to improve the performance
of PSi interferometers of a factor 105 with respect to the cova-
lently biofunctionalized counterpart used as control, both in
terms of LoD (600 fM) and sensitivity (49 nM−1). This also
represents a 300-fold improvement with respect to the best PSi
biosensors reported in the current literature, pushing PSi bio-
sensors to performance comparable to that of best state-of-the-art
nanostructured photonic and plasmonic platforms for biosensing,
namely, SPR, LSPR, interferometers, ring resonators, optical
ﬁbers, and photonic crystals.
Notice that, these latter platforms commonly require accurate
surface patterning and complex interrogation setups, which is not
the case of PSi interferometers. Further, both stability and ana-
lytical performance of LbL-biofunctionalized PSi interferometers
are successfully assessed in a complex body ﬂuid, namely saliva
(non-ﬁltered) spiked with streptavidin. This makes LbL-
biofunctionalized PSi interferometers a very appealing platform
for low-cost and high-sensitivity point-of-care biosensing.
By building on these results, it is straightforward to
envisage application of the LbL biofunctionalization route to
other state-of-the-art photonic and plasmonic platforms for
biosensing, both bulk and nanostructured, which would
possibly lead to a signiﬁcant improvement of their
performances in label-free afﬁnity biosensing, beyond those
achieved using standard covalent chemistry. On the other hand,
further development of the LbL biofunctionalization route by
eitherengineering polyelectrolytes with different bioreceptors, e.g.,
DNA strands, or using different/stronger polyelectrolytes, e.g.,
polystyrene sulfonate (pKa= 1), can be foreseen, which would
signiﬁcantly broaden ﬂexibility and applications of LbL
biofunctionalization.
Methods
Materials and chemicals. Silicon wafer boron doped, <100> oriented and with
resistivity of 0.8–1.2 mΩ-cm (p++-type), were purchased from Siltronix Silicon
Technologies (France). Aqueous hydroﬂuoric acid (HF, 48%) was purchased from
Merck Millipore (Massachusetts, USA). Absolute ethanol (99.9%), isopropyl
alcohol (99.5%), and diethylether were purchased from Carlo Erba Reagents S.r.l
(Italy). Streptavidin from Streptomyces avidinii (pI= 5.0, MW= 60 kDa) to be
used for afﬁnity biosensing and to be linked with Sulfo-rhodamine was purchased
from Fisher Scientiﬁc. Toluene (99.8%), APTES (99%), sodium hydroxide (NaOH
> 98%), sodium chloride (NaCl 99%), acetic acid (CH3COOH, 99.5%), sodium
acetate (CH3COONa 99%), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES 99.5%), biotin 3-sulfo-N-hydroxysuccinimide ester sodium salt, BSA (pI
= 4.7, MW= 66 kDa), pepsin (pI= 1, MW= 35 kDa), biotin amine, diethylether
(Et2O), triﬂuoroacetic acid (TFA), and 2-(4-hydroxyphenylazo)benzoic acid
(HABA) were purchased from Sigma Aldrich (Germany). PAH (40,000 Da) was
purchased from Beckmann-Kenko (Germany). PMAA was purchased from Poly-
sciences (Germany). N-hydroxysuccinimide (NHS), N,N’-dicyclohex-
ylcarbodiimide (DCC), N-boc-ethylenediamine, N-(3-dimethylaminopropyl)-N
′-ethylcarbodiimide hydrochloride (EDC), and N,N-dimethylformamide (DMF)
were purchased from Fluka. The labeling procedures were performed by common
coupling procedures46, with subsequent dialysis using membranes of 15 kD
MWCO (Aldrich). Acetate buffer (10.0 mM CH3COOH/CH3COONa) adjusted to
a pH= 5 was used for stock solution preparation from lyophilized streptavidin (20
mgmL−1) and stored at −20 °C. Acetate buffer (10.0 mM CH3COOH/
CH3COONa) with the addition of 100 mM NaCl was employed as runner/binding
buffer during biosensing measurements and for the serial dilution of the strepta-
vidin stock solution. Sodium acetate buffer (50 mM CH3COONa) with the addition
of 0.2 M NaCl and adjusted to a pH= 5.6 was used for the solubilization of PAH,
PMAA, and PMAA biotinylated polymers (1 mgmL−1) for LbL coating. HEPES
buffer (10.0 mM) with 100 mM NaCl and adjusted to a pH= 7.4 was used for the
rinsing step after the afﬁnity interaction between biotin and streptavidin.
PBS buffer (100 mM) with 100 mM NaCl and adjusted to a pH= 7.4 was used
for the stability test on the LbL assembly and for the biotinylation of the silanized
PSi oxidized surface.
All buffers were prepared in deionized water (DIW), ﬁltered using syringe ﬁlters
(Minisart® NML Syringe Filters 1.20 µm) and pH-adjusted with NaOH (5M) and
HCl (1 M) aqueous solution.
Preparation and oxidation of PSi interferometers. PSi samples were prepared by
anodic etching of polished silicon wafer (1.5 × 1.5 cm) with a solution of HF (48%):
EtOH, 3:1 v/v at 18 °C. A two-electrodes Teﬂon cell equipped with a platinum wire
cathode and an aluminum ﬂat anode was employed for the etching of the silicon
samples over a circular area of 0.567 cm2. A Keithley 2602A SourceMeter was used
to set the etching current density and measure the etching voltage.
A ﬁrst PSi sacriﬁcial layer was etched at 700 mA cm−2 for 10 s and dissolved by
alkaline dissolution with a solution of NaOH (1M):EtOH 9:1 v/v to avoid the
formation of a top parasitic layer (with pores of a few nanometers in diameter)
restricting the diffusion of both LbL polymers, e.g., PAH and PMAA, and target
biomolecules, e.g., streptavidin (~5 nm diameter), inside the PSi layer
underneath47. The silicon samples were rinsed with abundant DIW and ethanol,
and dried under a gentle nitrogen ﬂow.
The PSi sensing layer (i.e., the PSi interferometer) was then etched at 600 mA
cm−2 for 25 s on the so-processed silicon samples, rinsed with isopropanol and
diethylether, and gently dried under a nitrogen ﬂow to achieve a crack-free PSi
layer. Eventually, a thermal oxidation of the PSi interferometer was carried out in a
mufﬂe furnace (ZB 1, ASAL, Italy) at 750 °C for 1 h (ramp-up/ramp-down 12 °C
min−1) in room atmosphere.
Characterization of PSi interferometers. Reﬂectance spectra of the PSi inter-
ferometers were acquired in air (both before and after oxidation) in the wavelength
range [400−1000 nm] using an optical setup consisting of a UV−VIS spectrometer
(USB2000-VIS-NIR-ES), a bifurcated ﬁber-optic probe (QR200−7-VIS-BX), and a
halogen lamp source (HL-2000) purchased from Ocean Optics (USA). Light exiting
the halogen lamp source is fed orthogonally onto the PSi surface through one arm
of the ﬁber-optic probe; the light reﬂected from the PSi layer is collected into a UV
−VIS spectrometer through the other arm of the ﬁber-optic probe. Acquisition
parameters for reﬂection spectra were: integration time 2 ms, average scan number
5, boxcar width 5, with the spectrometer working in photon counts mode.
Porosity of as-prepared PSi interferometers was estimated by best-ﬁtting of the
reﬂectance spectra of PSi layers acquired before oxidation, using a home-made
software (Matlab, MathWorks, USA)48. Morphological characterization of as-
prepared PSi interferometers (i.e., diameter and thickness of the pores) was
performed on PSi layers before oxidation, using a scanning electron microscope
(SEM, JSM-6390, JEOL, Italy) at an accelerating voltage of 5 kV and an Atomic
Force Microscope (AFM Edge, Brucker, USA) in tapping mode. Distribution of the
pore diameters was obtained from the analysis of both SEM and AFM images with
ImageJ49.
Reproducibility of PSi preparation and oxidation was assessed by FFT of the
reﬂectance spectra of PSi interferometers, acquired before and after oxidation,
through calculation of EOT values (see section FFT reﬂectance spectroscopy).
Biotinylation of PMAA. Biotinylation of PMAA was carried out under dry con-
ditions. In all, 1.22 g biotin (5.0 mmol, 1.00 eq) was added to a two-neck round-
bottom ﬂask, followed by 0.60 g NHS (5.2 mmol, 1.04 eq) dissolved in 20 mL DMF.
In total, 1.20 g DCC (5.8 mmol, 1.16 eq) in 8 mL DMF was added dropwise using a
dropping funnel, which was then rinsed with 2 mL DMF to transfer all the material.
The mixture was heated at 75 °C until consumption of biotin checked by thin layer
chromatography (TLC) (acetonitrile, water, acetic acid, 90:10:1). After 1 h, 0.80 g
N-boc-ethylenediamine (792 μL, 5.0 mmol, 1.00 eq) in 4 mL DMF was added
subsequently to the suspension, followed by 2.8 mL triethylamine (20.0 mmol, 4.00
eq). The reaction mixture was heated at 75 °C until consumption of the inter-
mediate checked by TLC (acetonitrile, water, acetic acid, 90:10:1). After 30 min, the
reaction mixture was ﬁltered to remove the dicyclohexylurea by-product and the
ﬁltrate was concentrated under reduced pressure and an off-white solid was
obtained. The crude product was re-crystallized from isopropanol. The pale-yellow
solid was washed with Et2O to ﬁnally obtain a white solid. To the white solid 40 mL
DCM and 12mL TFA (156.8 mmol, 31.20 eq) were added and the mixture was
reﬂuxed for 10 min. The solvent was evaporated under reduced pressure and the
product was freeze-dried to obtain the biotin-amine TFA salt as an off-white solid
in 50 % yield (0.96 mg, 2.5 mmol).
Biotinylated PMAA polymers with theoretical labeling degrees of 1:20, 1:10, and
1:5 (biotin:PMAA monomer) were synthesized by amide coupling of PMAA with
different amounts of biotin-amine TFA salt. For each labeling degree, 50 mg
PMAA were dissolved in 0.5 mL 0.1 M HEPES pH 7.4. To each sample, 60 mg EDC
(0.31 mmol) in 250 μL 0.1 M HEPES pH 7.4 and 17.5 mg NHS (0.15 mmol) in 250
μL 0.1 M HEPES pH 7.4 were added. The mixture was stirred for 1 h and an
additional 1 mL 0.1 M HEPES pH 7.4 was added. Biotin-amine TFA salt (10 mg,
25 mg, and 50 mg) dissolved in 1 mL DMSO was added in order to obtain three
different polymers with three different biotinylation degrees. The mixtures were
stirred for 2 days at room temperature and dialyzed for 1 week using a dialysis
membrane and concentrated under reduced pressure to obtain the biotinylated
PMAA polymers.
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Labeling degree of biotinylated PMAA. The experimental degree of biotinylation
was determined using the 4′-hydroxyazobenzene-2-carboxylic acid (HABA) assay.
The HABA assay is based on the binding of HABA to streptavidin, which generates
a colored complex absorbing at 500 nm. Biotin has the ability to displace HABA
from the complex, proportionately decreasing the adsorption50. The experimental
degrees of biotinylation were 1:65, 1:40, and 1:30.
A solution containing 100 μL of streptavidin 0.5 mgmL−1 in 50 mM K3PO4 and
150 mM NaCl at pH 6 was prepared and 2.5 μL of HABA 10mM in 10mM NaOH
were added. To this solution 1 μL of biotinylated PMAA 10 mgmL−1 in water was
added. The absorbance at 500 nm was measured and the amount of biotin was
calculated using a calibration curve.
LbL functionalization of PSi interferometers. Oxidized PSi interferometers were
ﬁrst LbL coated with PAH (1mgmL−1), which is a positively charged polyelec-
trolyte, exploiting electrostatic attraction with the negatively charged oxidized
surface of PSi interferomters. The PAH solution (100 µL) was drop-cast onto the
oxidized PSi interferometers and left incubating for 2 h at 18 °C to ensure full
inﬁltration of the nanopores of the PSi layer. The samples were then abundantly
rinsed with DIW and ethanol, and gently dried under a nitrogen ﬂow. The PAH-
coated PSi interferometers were then LbL coated with either bare and biotynilated
PMAA at 18 °C, which is a negatively charged polyelectrolyte, exploiting electro-
static interaction with PAH. The PMAA solution (100 µL, 1 mgmL−1) was
dropped onto the PAH-PSi interferometers and left incubating for 2 h at room
temperature to ensure full inﬁltration of the PAH-coated nanopores. The samples
were then abundantly rinsed with DIW and ethanol, and gently dried under a
nitrogen ﬂow. The same coating protocol was followed also for sulfo-rhodamine-
labeled PAH and ﬂuorescein-labeled PMAA charged polymers.
Reﬂection spectra of PSi interferometers after each LbL-coating step (i.e., PAH
and PMAA) were acquired in air (using the same protocol reported in section
Characterization of PSi interferometers). Successful LbL coating of PSi
interferometer was conﬁrmed by FFT of the acquired reﬂectance spectra, through
calculation of the EOT value (see section FFT reﬂectance spectroscopy). Optical
microscope (Leica DM2500 M), equipped with a ﬁlter cube for green and red
ﬂuorescence, was used to further corroborate LbL coating of PSi interferometers,
using sulfo-rhodamine-labeled PAH and ﬂuorescein-labeled PMAA.
Covalent biotinylation of oxidized PSi interferometers. The covalent biotiny-
lation of the oxidized PSi surface was based on the silanization chemistry with
APTES (silane).
Oxidized PSi interferometers were incubated with 1% APTES (10 mL) in
anhydrous toluene for 1 h51. After incubation, the PSi samples were abundantly
rinsed with toluene and ethanol, and gently dry under a nitrogen ﬂow. PSi samples
were baked at 150 °C for 30 min to further stabilize the APTES layer52, then rinsed
in PBS buffer to remove either hydrolyzed or multilayered silanes. FFT reﬂectance
spectroscopy was employed to conﬁrm the occurred silanization of PSi
inteferometers (Supplementary Figure 5a, b).
Covalent biotinylation of APTES-coated PSi interferometers was carried out
using Biotin 3-sulfo-N-hydroxysuccinimide ester sodium salt solubilized in PBS
(10 g mL−1 ~ 22.5 mM). PBS buffer (pH= 7.4) was chosen taking into account that
Biotin 3-sulfo-N-hydroxysuccinimide couples to primary amines in the pH range
6.5–8.5. The covalent biotinylation of the amino-group was conﬁrmed by IAWRS
(Supplementary Figure 5c).
FFT reﬂectance spectroscopy. FFT of the reﬂectance spectra of PSi inter-
ferometers was performed to calculate the EOT values, namely, 2nL, where n=
effective refractive index and L= thickness of the PSi layer, using a home-made
software (MatLab, MathWorks, USA). The wavelength axis of the reﬂectance
spectrum was ﬁrst inverted (x axis changed from wavelength to 1/wavelength) to
obtain a wavenumber axis. A cubic-spline interpolation of reﬂectance data was
then carried out to obtain a dataset (reﬂection, wavenumber) spaced evenly
(sample-to-sample distance 8.57 × 10−7 nm−1). A Hanning window was applied to
the reﬂectance spectrum, which was zero padded to 224. Eventually, application of
the FFT algorithm to the zero-padded reﬂectance spectrum yielded the Fourier
transform amplitude and phase (y axis in the Fourier transform domain) as a
function of 1/wavenumber (x axis in the Fourier transform domain), with spatial
resolution of about 0.07 nm. The EOT value is obtained as the value of the 1/
wavenumber axis (x axis) in the Fourier transform domain for which the main
peak in the Fourier transform amplitude (y axis) occurs.
Biosensing protocol of biofunctionalized PSi interferometers. The ﬁber-optic
setup previously described in section Characterization of PSi interferometers was
integrated with a ﬂow cell system (as depicted in the Supplementary Information of 53)
for the monitoring of: (1) the unspeciﬁc interaction between PMAA and proteins
(i.e., streptavidin, pepsin and BSA, at a concentration of 500 µg mL−1); (2) the
selective interaction between b-PMAA (1:65), b-PMAA (1:40), and b-PMAA (1:30)
and 8.3 µM (500 µg mL−1) streptavidin; (3) the biosensing interaction between
streptavidin, at concentration ranging from 8.3 pM to 8.3 µM, and b-PMAA (1:30).
The PSi interferometers were secured into a home-made Plexiglas ﬂow cell
provided with a PDMS o-ring (volume of 100 μL). Solutions under test were
injected in the ﬂow cell through a syringe pump (Nexus 3000, Chemyx Inc., USA)
working in withdraw mode.
First, acetate buffer (running buffer) was injected at a ﬂow rate of 5 μLmin−1
for a warm-up time of 60 min, to make sure that both ﬂuidic and thermal
transients were over. After warm-up, acetate buffer was further injected for 30–40
min, then protein solutions (i.e., streptavidin, BSA, or pepsin) at different
concentrations were injected for 40 min at a ﬂow rate of 5 μLmin−1 (200 μL total
volume injected). After injection of a protein solution with a speciﬁc concentration,
a ﬁrst rinsing step in acetate buffer was carried out at a ﬂow rate of 100 μLmin−1
for 20–30 min to remove both weakly adsorbed proteins on the PMAA matrix and
unbounded proteins present in the bulk media. A further repulsive rinsing step
with HEPES buffer was then performed at a ﬂow rate of 100 μLmin−1 for 20–30
min, in order to desorb proteins nonspeciﬁcally adsorbed on PMAA (either
biotinylated or bare). Eventually, acetate buffer was injected again in the ﬂow cell at
a ﬂow rate of 5 µL min−1 for 20 min, before injection of a protein solution with a
novel concentration.
Notice that, the repulsive rinse with HEPES buffer, which was speciﬁcally
developed for the LbL assembly, was bypassed for covalent-biotynilated PSi
interferometers.
Reﬂection spectra of PSi interferometers were acquired every minute over the
whole biosensing experiment. Acquisition parameters of reﬂection spectra were:
integration time 2 ms, average scan number 5, boxcar width 5, with the
spectrometer working in normalized reﬂection mode.
Saliva sampling and biosensing measurements in saliva. Saliva (1–2 mL) was
sampled from a health human male volunteer (after tooth brushing in the morning,
1 h before sampling), upon written informed consent. The saliva was spit in a
sterilized Petri dish and then immediately vacuumed for 30 min to remove air
bubbles that could compromise the correct operation mode of the ﬂuidic systems
and the correct interference spectra acquisition. An aliquot of the sampled saliva
(100 µL) was diluted 1:10 in acetate buffer (running/binding buffer reported in
Materials and chemicals paragraph). An aliquot of the diluted real matrix (i.e., 200
µL) was directly injected (without any ﬁltration or puriﬁcation) in the ﬂow cell for
testing the LbL assembly stability and using the same injection protocol (with
repulsive rinse) described in Biosensing with LbL-biofunctionalized PSi inter-
ferometers paragraph. The stability of the LbL assembly was evaluated monitoring
the EOT changes of the LbL-coated PSi surface accordingly to Stability of LbL
assembly with pH and ionic strength paragraph reported in Results section.
Once the stability was assessed, the binding properties of the biotinylated
surface in complex matrix were evaluated testing aliquots of saliva (1:10 diluted in
acetate buffer) spiked with 83, 830, and 8300 nM (i.e., 5, 50, and 500 µg mL−1) of
streptavidin accordingly to the injection protocol described in Biosensing with LbL-
biofunctionalized PSi interferometers paragraph. The bindings curves were
monitored by IAW reﬂectance spectroscopy and the obtained IAW-IAW0 signals
were compared with the same obtained in only acetate buffer for the same
streptavidin concentrations.
Biosensing measurement by IAWRS. The IAW Reﬂectance Spectroscopy33,41
was used to monitor: stability of the LbL assembly at different pH and ionic
strength buffers; unspeciﬁc interaction between streptavidin, pepsin, BSA, and
PMAA; biosensing measurements with streptavidin on LbL-biofunctionalized PSi
interfermeters; as well as, biosensing measurements with streptavidin on covalently
biotinylated PSi interferometers.
Reﬂectance spectra acquired on PSi interferometers were normalized with
respect to a reference mirror (Ø1“Protected Silver Mirror, Thorlabs, USA). Spectral
interferograms were calculated by subtraction (intensity, wavelength by
wavelength) of the reﬂectance spectrum acquired after each injection (i.e., protein,
buffer, linkers) from the reference reﬂectance spectrum acquired in the running
buffer (i.e., acetate). An interferogram was also calculated for the running buffer
(namely, blank interferogram) by subtraction of the reﬂectance spectrum acquired
in acetate buffer before starting injecting the protein solutions (t= 100 min) from
the reﬂectance spectrum acquired after the 60-min-long warm-up time (t= 60
min). Each interferogram was then corrected for its average value, which was
subtracted from the interferogram to limit artifacts due to spectral reﬂection
changes of intensity induced by biomolecules adsorption on the top of the PSi
sensing layer, and/or on the quartz window of the ﬂow cell. Eventually, the output
signal, namely, IAW, was obtained by application of the absolute value function to
each so-processed interferogram and subsequent calculation of the average value of
the resulting interferogram over the spectral range of interest [500−800 nm]. A
schematic description of the whole IAWRS strategy is shown in Supplementary
Figure 7, with speciﬁc reference to an LbL-biofunctionalized PSi interferometer
with b-PMAA (1:30) upon injection of the highest steptravidin concentration
tested (i.e., 8.3 µM).
Study approval. Saliva was obtained from a volunteer upon written informed
consent prior to inclusion in the study. The study protocol was approved by the
Committee on Bioethics of the University of Pisa (review no. 3/2018).
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